UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported): February 9, 2017

 

 

MEDICAL PROPERTIES TRUST, INC.

(Exact Name of Registrant as Specified in Charter)

 

 

Commission File Number 001-32559

 

Maryland		20-0191742
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

 

1000 Urban Center Drive, Suite 501 Birmingham, AL		35242
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code

(205) 969-3755

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions:

 

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

---

Item 2.02. Results of Operations and Financial Condition.

On February 9, 2017, Medical Properties Trust, Inc. issued a press release announcing its financial results for the quarter and year ended December 31, 2016. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The information in this Current Report on Form 8-K, including the information set forth in Exhibit 99.1 and Exhibit 99.2 attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended. In addition, this information shall not be deemed incorporated by reference in any filing of Medical Properties Trust, Inc. with the Securities and Exchange Commission, except as expressly set forth by specific reference in any such filing.

The Company disclosed three non-GAAP financial measures in the attached press release for the quarter and year ended December 31, 2016: Funds from operations, Normalized funds from operations and Adjusted funds from operations. The most directly comparable GAAP financial measure to each of these non-GAAP financial measures is net income, which was $43.0 million, or $0.13 per diluted share for the quarter ended December 31, 2016, compared to $58.2 million, or $0.24 per diluted share for the quarter ended December 31, 2015. For the year ended December 31, 2016, net income was $225.0 million, or $0.86 per diluted share compared to $139.6 million, or $0.63 per diluted share for the year ended December 31, 2015. In the attached press release, the Company disclosed Funds from operations of $69.9 million and $253.5 million for the quarter and year ended December 31, 2016, respectively, and Normalized funds from operations of $100.7 million and $334.8 million for the quarter and year ended December 31, 2016, respectively. Adjusted funds from operations were disclosed in the press release as $87.4 million and $298.5 million for the quarter and year ended December 31, 2016, respectively.

A reconciliation of the non-GAAP financial measures to net income as well as a statement disclosing the reasons why the Company’s management believes that presentation of these non-GAAP financial measures provides useful information to investors regarding the Company’s financial condition and results of operations are included in Exhibits 99.1 and 99.2.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

 

Exhibit Number		Description
99.1		Press release dated February 9, 2017 reporting financial results for the quarter and year ended December 31, 2016
99.2		Medical Properties Trust, Inc. 4th Quarter 2016 Supplemental Information

 

2

---

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunder duly authorized.

 

Date: February 9, 2017

 

3

---

INDEX TO EXHIBITS

 

Exhibit Number		Description
99.1		Press release dated February 9, 2017 reporting financial results for the quarter and year ended December 31, 2016
99.2		Medical Properties Trust, Inc. 4th Quarter 2016 Supplemental Information

 

4

Exhibit 99.1

 

 

				Contact: Tim Berryman
				Director – Investor Relations
				Medical Properties Trust, Inc.
				(205) 969-3755 tberryman@medicalpropertiestrust.com

MEDICAL PROPERTIES TRUST, INC. REPORTS FOURTH QUARTER RESULTS

Per Share Normalized FFO of $0.31 and Net Income of $0.13

Completes Balance Sheet Restructuring with New Credit Facility

Birmingham, AL – February 9, 2017 – Medical Properties Trust, Inc. (the “Company” or “MPT”) (NYSE: MPW) today announced financial and operating results for the fourth quarter and year ended December 31, 2016 through 2017’s first quarter.

“In 2016 and through the early days of 2017, MPT achieved all of the operational goals we set early in the year,” said Edward K. Aldag, Jr., MPT’s Chairman, President and Chief Executive Officer. “We successfully and profitably repositioned our portfolio by capturing sizable gains from asset sales in the first half and allocating capital to compelling new opportunities in the second half. The approximate $800 million in asset sales, and our solid execution in the capital markets, helped to significantly strengthen our balance sheet, reduce leverage, improve liquidity, and position the company for long-term growth.

“In the fourth quarter, we added Steward Health Care to our portfolio of 247 hospitals. Forward-thinking operators, such as Steward, have proven their ability to effectively navigate the changing landscape of healthcare and profitably provide quality care to their patients, especially during times of dramatically changing hospital environments such as the implementation of – and now the unwinding of – the Affordable Care Act. We see significant acquisition opportunities ahead as operators with proven healthcare delivery models look to expand into new markets with the assistance of MPT.”

FOURTH QUARTER AND RECENT HIGHLIGHTS

 

•

Normalized Funds from Operations (“FFO”) per diluted share was $0.31 in the fourth quarter compared with $0.35 in fourth quarter of 2015;

 

•

On a full year basis 2016’s Normalized FFO per share increased to $1.28 compared to $1.26 per diluted share in 2015, an increase even in a year of significant asset sales;

 

•

Acquisitions reported in 2016 totaled approximately $1.8 billion, continuing the trajectory of highly and immediately accretive growth, compared to approximately $1.7 billion in 2015 and $1.4 billion in 2014;

 

1

---

•

Completed the previously announced acquisition of real estate interests in nine Steward Health Care hospitals in early October for a total investment of $1.25 billion;

 

•

Completed acquisitions of 12 post-acute hospitals to be operated by MEDIAN and its affiliates in Germany in the fourth quarter for a total investment of approximately $90 million as part of previously announced acquisitions aggregating $282 million (based on recent exchange rates);

 

•

Completed a new $1.7 billion senior unsecured credit facility with improved pricing in early February 2017; includes a $1.3 billion senior unsecured revolving credit facility, a $200 million senior unsecured term loan, and a €200 million senior unsecured term loan;

 

•

Gave redemption notice for €200 million 5.750% Senior Notes due 2020 to be redeemed with funds from the €200 million senior unsecured term loan included in the new $1.7 billion credit facility and cash on hand.

Included in the financial tables accompanying this press release is information about the Company’s assets and liabilities, net income and reconciliations of net income to FFO and Adjusted Funds from Operations (“AFFO”), all on a basis comparable to 2015 results.

PORTFOLIO UPDATE

During and after the fourth quarter, MPT made investments in hospital real estate totaling approximately $1.4 billion that was leased to operators under long-term absolute net leases with GAAP lease rates between 9.5% and 10.5%.

As of December 31, 2016, MPT has leased 59 facilities to Adeptus, with an aggregate investment of approximately $446 million and an aggregate lease coverage ratio for 43 open facilities of approximately 2.62 times for the twelve months ended September 30, 2016. Adeptus has prepaid all rent through February and, based on facility openings in the fourth quarter of 2016, total revenue from Adeptus is approximately 7% of MPT’s estimated 2017 total revenue. As of December 31, 2016, 64% of MPT’s Adeptus investments are leased to joint ventures or partnerships with dominant, market leading hospital systems in each market, and 88% of MPT’s facilities are being operated as Hospital Outpatient Departments. Among other arrangements, MPT remains beneficiary of irrevocable letters of credit for an amount equal to approximately four months anticipated cash rent.

The Company has pro forma total gross assets of approximately $7.1 billion including $4.7 billion in general acute care hospitals, $1.7 billion in inpatient rehabilitation hospitals, and $0.4 billion in long-term acute care hospitals. The portfolio includes 247 properties representing more than 27,000 licensed beds in 30 states and in Germany, the United Kingdom, Italy and Spain. The properties are leased to or mortgaged by 30 hospital operating companies.

OPERATING RESULTS AND OUTLOOK

Normalized FFO for the fourth quarter increased 22% to $100.7 million compared with $82.5 million in the fourth quarter of 2015. Per share Normalized FFO decreased 11% to $0.31 per diluted share in the fourth quarter compared with $0.35 per share in the fourth quarter of 2015 due to asset sales and completion of planned deleveraging to a sector leading ratio of approximately 5.1 times pro forma net debt to EBITDA.

 

2

---

For the twelve months ended December 31, 2016, Normalized FFO increased 22% to $334.8 million from $274.8 million in 2015. On a per diluted share basis, Normalized FFO increased 2% in 2016 to $1.28 from $1.26 in 2015.

Fourth quarter 2016 total revenues increased 17% to $153.3 million compared with $131.5 million for the fourth quarter of 2015. Revenue for the twelve months ended December 31, 2016 increased 22% to $541.1 million from $441.9 million in 2015.

Net income for the fourth quarter of 2016 was $43.0 million (or $0.13 per diluted share), compared to $58.2 million (or $0.24 per diluted share) in the fourth quarter of 2015. Net income for the twelve months ended December 31, 2016 was $225.0 million (or $0.86 per diluted share) compared with net income of $139.6 million (or $0.63 per diluted share) in 2015.

The Company reaffirms 2017 Normalized FFO guidance between $1.35 and $1.40 per diluted share and 2017 net income as a range of between $0.97 and $1.03 per diluted share. These estimates assume acquisitions of between $500 million and $1.0 billion with leverage neutral financing; sales of $75 million of properties in early 2017; and completion of previously announced acquisitions and lease backs.

These estimates do not include the effects, if any, of real estate operating costs, litigation costs, debt refinancing costs, acquisition costs, currency exchange rate movements, change in accounting principles, interest rate hedging activities, write-offs of straight-line rent or other non-recurring or unplanned transactions. These estimates may change when the Company acquires or sells assets, market interest rates change, debt is refinanced, new shares are issued, additional debt is incurred, other operating expenses vary, income from investments in tenant operations vary from expectations, or existing leases do not perform in accordance with their terms.

CONFERENCE CALL AND WEBCAST

The Company has scheduled a conference call and webcast for Thursday, February 9, 2017 at 11:00 a.m. Eastern Time to present the Company’s financial and operating results for the quarter and year ended December 31, 2016. The dial-in numbers for the conference call are 855-365-5214 (U.S.) and 440-996-5721 (international); both numbers require passcode 52407751. The conference call will also be available via webcast in the Investor Relations’ section of the Company’s website, www.medicalpropertiestrust.com.

A telephone and webcast replay of the call will be available beginning shortly after the call’s completion through February 23, 2017. Dial-in numbers for the replay are 855-859-2056 and 404-537-3406 for U.S. and International callers, respectively. The replay passcode for both U.S. and international callers is 52407751.

The Company’s supplemental information package for the current period will also be available on the Company’s website under the “Investor Relations” section.

About Medical Properties Trust, Inc.

Medical Properties Trust, Inc. is a self-advised real estate investment trust formed to capitalize on the changing trends in healthcare delivery by acquiring and developing net-leased healthcare

 

3

---

facilities. MPT’s financing model allows hospitals and other healthcare facilities to unlock the value of their underlying real estate in order to fund facility improvements, technology upgrades, staff additions and new construction. Facilities include acute care hospitals, inpatient rehabilitation hospitals, long-term acute care hospitals, and other medical and surgical facilities. For more information, please visit the Company’s website at www.medicalpropertiestrust.com.

The statements in this press release that are forward looking are based on current expectations and actual results or future events may differ materially. Words such as “expects,” “believes,” “anticipates,” “intends,” “will,” “should” and variations of such words and similar expressions are intended to identify such forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results of the Company or future events to differ materially from those expressed in or underlying such forward-looking statements, including without limitation: the satisfaction of all conditions to, and the timely closing (if at all) of pending transactions; net income per share; Normalized FFO per share; the amount of acquisitions of healthcare real estate, if any; results from the potential sales, if any, of assets; capital markets conditions; estimated leverage metrics; the repayment of debt arrangements; statements concerning the additional income to the Company as a result of ownership interests in certain hospital operations and the timing of such income; the payment of future dividends, if any; completion of additional debt arrangements, and additional investments; national and international economic, business, real estate and other market conditions; the competitive environment in which the Company operates; the execution of the Company’s business plan; financing risks; the Company’s ability to maintain its status as a REIT for income tax purposes; acquisition and development risks; potential environmental and other liabilities; and other factors affecting the real estate industry generally or healthcare real estate in particular. For further discussion of the factors that could affect outcomes, please refer to the “Risk factors” section of the Company’s Annual Report on Form 10-K for the year ended December 31, 2015 and as updated by the Company’s subsequently filed Quarterly Reports on Form 10-Q and other SEC filings. Except as otherwise required by the federal securities laws, the Company undertakes no obligation to update the information in this press release.

# # #

 

4

---

MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES

Consolidated Balance Sheets

 

(Amounts in thousands, except for per share data)		December 31, 2016				December 31, 2015
		(Unaudited)				(A)
Assets
Real estate assets
Land, buildings and improvements, intangible lease assets, and other		$	4,317,866			$	3,297,705
Net investment in direct financing leases			648,102				626,996
Mortgage loans			1,060,400				757,581
Gross investment in real estate assets			6,026,368				4,682,282
Accumulated depreciation and amortization			(325,125	)			(257,928	)
Net investment in real estate assets			5,701,243				4,424,354
Cash and cash equivalents			83,240				195,541
Interest and rent receivables			57,698				46,939
Straight-line rent receivables			116,861				82,155
Other assets			459,494				860,362
Total Assets		$	6,418,536			$	5,609,351
Liabilities and Equity
Liabilities
Debt, net		$	2,909,341			$	3,322,541
Accounts payable and accrued expenses			207,711				137,356
Deferred revenue			19,933				29,358
Lease deposits and other obligations to tenants			28,323				12,831
Total Liabilities			3,165,308				3,502,086
Equity
Preferred stock, $0.001 par value. Authorized 10,000 shares; no shares outstanding			—				—
Common stock, $0.001 par value. Authorized 500,000 shares; issued and outstanding - 320,514 shares at December 31, 2016 and 236,744 shares at December 31, 2015			321				237
Additional paid-in capital			3,775,336				2,593,827
Distributions in excess of net income			(434,114	)			(418,650	)
Accumulated other comprehensive loss			(92,903	)			(72,884	)
Treasury shares, at cost			(262	)			(262	)
Total Medical Properties Trust, Inc. Stockholders’ Equity			3,248,378				2,102,268
Non-controlling interests			4,850				4,997
Total Equity			3,253,228				2,107,265
Total Liabilities and Equity		$	6,418,536			$	5,609,351

 

(A)	Financials have been derived from the prior year audited financial statements.

---

MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES

Consolidated Statements of Income

 

(Amounts in thousands, except for per share data)		For the Three Months Ended								For the Twelve Months Ended
		December 31, 2016				December 31, 2015				December 31, 2016				December 31, 2015
		(Unaudited)				(Unaudited)				(Unaudited)				(A)
Revenues
Rent billed		$	92,861			$	70,253			$	327,269			$	247,604
Straight-line rent			14,558				8,372				41,067				23,375
Income from direct financing leases			17,126				18,660				64,307				58,715
Interest and fee income			28,738				34,261				108,494				112,184
Total revenues			153,283				131,546				541,137				441,878
Expenses
Real estate depreciation and amortization			26,524				20,140				94,374				69,867
Impairment charges			(66	)			—				7,229				—
Property-related			1,120				1,184				2,712				3,792
Acquisition expenses			39,894				4,345				46,273				61,342
General and administrative			13,090				11,314				48,911				43,639
Total operating expenses			80,562				36,983				199,499				178,640
Operating income			72,721				94,563				341,638				263,238
Interest expense			(38,465	)			(35,923	)			(159,597	)			(120,884	)
Gain (loss) on sale of real estate and other asset dispositions, net			(70	)			—				61,224				3,268
Unutilized financing fees/debt refinancing costs			—				(48	)			(22,539	)			(4,367	)
Other income (expense)			1,056				230				(1,618	)			175
Income tax benefit (expense)			8,003				(484	)			6,830				(1,503	)
Income from continuing operations			43,245				58,338				225,938				139,927
Loss from discontinued operations			—				—				(1	)			—
Net income			43,245				58,338				225,937				139,927
Net income attributable to non-controlling interests			(206	)			(100	)			(889	)			(329	)
Net income attributable to MPT common stockholders		$	43,039			$	58,238			$	225,048			$	139,598
Earnings per common share - basic:
Income from continuing operations		$	0.13			$	0.24			$	0.86			$	0.64
Loss from discontinued operations			—				—				—				—
Net income attributable to MPT common stockholders		$	0.13			$	0.24			$	0.86			$	0.64
Earnings per common share - diluted:
Income from continuing operations		$	0.13			$	0.24			$	0.86			$	0.63
Loss from discontinued operations			—				—				—				—
Net income attributable to MPT common stockholders		$	0.13			$	0.24			$	0.86			$	0.63
Dividends declared per common share		$	0.23			$	0.22			$	0.91			$	0.88
Weighted average shares outstanding - basic			319,833				237,011				260,414				217,997
Weighted average shares outstanding - diluted			319,994				237,011				261,072				218,304

 

(A)	Financials have been derived from the prior year audited financial statements.

---

MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES

Reconciliation of Net Income to Funds From Operations

(Unaudited)

 

(Amounts in thousands, except for per share data)		For the Three Months Ended								For the Twelve Months Ended
		December 31, 2016				December 31, 2015				December 31, 2016				December 31, 2015
FFO information:
Net income attributable to MPT common stockholders		$	43,039			$	58,238			$	225,048			$	139,598
Participating securities’ share in earnings			(129	)			(248	)			(559	)			(1,029	)
Net income, less participating securities’ share in earnings		$	42,910			$	57,990			$	224,489			$	138,569
Depreciation and amortization (A)			26,976				20,140				96,157				69,867
Gain on sale of real estate			—				—				(67,168	)			(3,268	)
Funds from operations		$	69,886			$	78,130			$	253,478			$	205,168
Write-off of straight line rent and other			—				—				3,063				3,928
Transaction costs from non-real estate dispositions			70				—				5,944				—
Acquisition expenses, net of tax benefit (A)			34,806				4,345				46,529				61,342
Release of valuation allowance			(3,956	)			—				(3,956	)			—
Impairment charges			(66	)			—				7,229				—
Unutilized financing fees / debt refinancing costs			—				48				22,539				4,367
Normalized funds from operations		$	100,740			$	82,523			$	334,826			$	274,805
Share-based compensation			2,111				2,521				7,942				10,237
Debt costs amortization			1,814				1,792				7,613				6,085
Additional rent received in advance (B)			(300	)			(300	)			(1,200	)			(1,200	)
Straight-line rent revenue and other			(16,921	)			(11,118	)			(50,687	)			(34,218	)
Adjusted funds from operations		$	87,444			$	75,418			$	298,494			$	255,709
Per diluted share data:
Net income, less participating securities’ share in earnings		$	0.13			$	0.24			$	0.86			$	0.63
Depreciation and amortization (A)			0.09				0.09				0.37				0.32
Gain on sale of real estate			—				—				(0.26	)			(0.01	)
Funds from operations		$	0.22			$	0.33			$	0.97			$	0.94
Write-off of straight line rent and other			—				—				0.01				0.02
Transaction costs from non-real estate dispositions			—				—				0.02				—
Acquisition expenses, net of tax benefit (A)			0.11				0.02				0.18				0.28
Release of valuation allowance			(0.02	)			—				(0.02	)			—
Impairment charges			—				—				0.03				—
Unutilized financing fees / debt refinancing costs			—				—				0.09				0.02
Normalized funds from operations		$	0.31			$	0.35			$	1.28			$	1.26
Share-based compensation			0.01				0.01				0.03				0.05
Debt costs amortization			0.01				0.01				0.02				0.03
Additional rent received in advance (B)			—				—				—				(0.01	)
Straight-line rent revenue and other			(0.06	)			(0.05	)			(0.19	)			(0.16	)
Adjusted funds from operations		$	0.27			$	0.32			$	1.14			$	1.17

 

(A)	For 2016, this includes our share of real estate depreciation and acquisition expenses from unconsolidated joint ventures (if any). Any such amounts are included with the activity of all of our equity interests in the “Other income (expense)” line on the consolidated statements of income.

(B)	Represents additional rent received from one tenant in advance of when we can recognize as revenue for accounting purposes.This additional rent is being recorded to revenue on a straight-line basis over the lease life.

Investors and analysts following the real estate industry utilize funds from operations, or FFO, as a supplemental performance measure. FFO, reflecting the assumption that real estate asset values rise or fall with market conditions, principally adjusts for the effects of GAAP depreciation and amortization of real estate assets, which assumes that the value of real estate diminishes predictably over time. We compute FFO in accordance with the definition provided by the National Association of Real Estate Investment Trusts, or NAREIT, which represents net income (loss) (computed in accordance with GAAP), excluding gains (losses) on sales of real estate and impairment charges on real estate assets, plus real estate depreciation and amortization and after adjustments for unconsolidated partnerships and joint ventures.

In addition to presenting FFO in accordance with the NAREIT definition, we also disclose normalized FFO, which adjusts FFO for items that relate to unanticipated or non-core events or activities or accounting changes that, if not noted, would make comparison to prior period results and market expectations less meaningful to investors and analysts. We believe that the use of FFO, combined with the required GAAP presentations, improves the understanding of our operating results among investors and the use of normalized FFO makes comparisons of our operating results with prior periods and other companies more meaningful. While FFO and normalized FFO are relevant and widely used supplemental measures of operating and financial performance of REITs, they should not be viewed as a substitute measure of our operating performance since the measures do not reflect either depreciation and amortization costs or the level of capital expenditures and leasing costs necessary to maintain the operating performance of our properties, which can be significant economic costs that could materially impact our results of operations. FFO and normalized FFO should not be considered an alternative to net income (loss) (computed in accordance with GAAP) as indicators of our financial performance or to cash flow from operating activities (computed in accordance with GAAP) as an indicator of our liquidity.

We calculate adjusted funds from operations, or AFFO, by subtracting from or adding to normalized FFO (i) unbilled rent revenue, (ii) non-cash share-based compensation expense, and (iii) amortization of deferred financing costs. AFFO is an operating measurement that we use to analyze our results of operations based on the receipt, rather than the accrual, of our rental revenue and on certain other adjustments. We believe that this is an important measurement because our leases generally have significant contractual escalations of base rents and therefore result in recognition of rental income that is not collected until future periods, and costs that are deferred or are non-cash charges. Our calculation of AFFO may not be comparable to AFFO or similarly titled measures reported by other REITs. AFFO should not be considered as an alternative to net income (calculated pursuant to GAAP) as an indicator of our results of operations or to cash flow from operating activities (calculated pursuant to GAAP) as an indicator of our liquidity.

---

MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES

Fiscal Year 2017 Guidance Reconciliation

(Unaudited)

 

		Fiscal Year 2017 Guidance - Per Share(1)
		Low				High
Net income attributable to MPT common stockholders		$	0.97			$	1.03
Participating securities’ share in earnings			—				—
Net income, less participating securities’ share in earnings		$	0.97			$	1.03
Depreciation and amortization			0.34				0.34
Funds from operations		$	1.31			$	1.37
Other adjustments(2)			0.04				0.03
Normalized funds from operations		$	1.35			$	1.40

 

(1)

The guidance is based on current expectations and actual results or future events may differ materially from those expressed in this table, which is a forward-looking statement within the meaning of the federal securities laws. Please refer to the forward-looking statement included in this press release and our filings with the Securities and Exchange Commission for a discussion of risk factors that affect our performance.

(2)	Includes acquisition expenses, write-off of straight line rent, transaction costs from non-real estate dispositions, impairment charges, unutilized fees/debt refinancing costs, and other.

Exhibit 99.2

 

MPT Medical Properties Trust
FOURTH QUARTER 2016
Supplemental Information

---

MEDICALPROPERTIESTRUST.COM
TABLE OF CONTENTS
COMPANY OVERVIEW
Company Information 3
FINANCIAL INFORMATION
Reconciliation of Net Income to Funds from Operations 5
Debt Summary 6
Pro Forma Debt Maturity Schedule 7
Pro Forma Net Debt /Annualized EBITDA 8
PORTFOLIO INFORMATION
Lease and Mortgage Loan Maturity Schedule 9
Investments and Revenue by Asset Type, Operator, State and Country 10
EBITDAR to Rent Coverage 13
Summary of Acquisitions and Development Projects 14
FINANCIAL STATEMENTS
Consolidated Statements of Income 15
Consolidated Balance Sheets 16
Other Income Generating Assets 17
FORWARD-LOOKING STATEMENT Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results of the Company or future events to differ materially from those expressed in or underlying such forward-looking statements, including without limitation: Normalized FFO per share; expected payout ratio, the amount of acquisitions of healthcare real estate, if any; estimated debt metrics, portfolio diversification, capital markets conditions, the repayment of debt arrangements; statements concerning the additional income to the Company as a result of ownership interests in certain hospital operations and the timing of such income; the payment of future dividends, if any; completion of additional debt arrangement, and additional investments; national and international economic, business, real estate and other market conditions; the competitive environment in which the Company operates; the execution of the Company’s business plan; financing risks; the Company’s ability to maintain its status as a REIT for federal income tax purposes; acquisition and development risks; potential environmental and other liabilities; and other factors affecting the real estate industry generally or healthcare real estate in particular. For further discussion of the factors that could affect outcomes, please refer to the “Risk Factors” section of the Company’s Annual Report on Form 10-K for the year ended December 31, 2015, and as updated by the Company’s subsequently filed Quarterly Reports on Form 10-Q and other SEC filings. Except as otherwise required by the federal securities laws, the Company undertakes no obligation to update the information in this report.
On the Cover: Carney Hospital (Steward Health Care) - Dorchester, Massachusetts. Acquired in 2016.
Q4 2016 | SUPPLEMENTAL INFORMATION 2

---

MEDICALPROPERTIESTRUST.COM
COMPANY OVERVIEW
MPT Medical Properties Trust, Inc. is a Birmingham, Alabama based self-advised real estate investment trust formed to capitalize on the changing trends in healthcare delivery by acquiring and developing net-leased healthcare facilities. MPT’s financing model allows hospitals and other healthcare facilities to unlock the value of their underlying real estate in order to fund facility improvements, technology upgrades, staff additions and new construction. Facilities include acute care hospitals, inpatient rehabilitation hospitals, long-term acute care hospitals, and other medical and surgical facilities.
OFFICERS
Edward K. Aldag, Jr. Chairman, President and Chief Executive Officer
R. Steven Hamner Executive Vice President and Chief Financial Officer
Emmett E. McLean Executive Vice President, Chief Operating Officer, Treasurer and Secretary
J. Kevin Hanna Vice President, Controller and Chief Accounting Officer
BOARD OF DIRECTORS
Edward K. Aldag, Jr.
G. Steven Dawson
R. Steven Hamner
Robert. E. Holmes, Ph.D.
Sherry A. Kellett
William G. McKenzie
D. Paul Sparks, Jr.
Michael G. Stewart
C. Reynolds Thompson, III
CORPORATE HEADQUARTERS
Medical Properties Trust, Inc.
1000 Urban Center Drive, Suite 501 Birmingham, AL 35242
(205) 969-3755 (205) 969-3756 (fax) www.medicalpropertiestrust.com
MPT Officers, from left: J. Kevin Hanna, Emmett E. McLean, Edward K. Aldag, Jr., and R. Steven Hamner.
Q4 2016 | SUPPLEMENTAL INFORMATION 3

---

MEDICALPROPERTIESTRUST.COM
COMPANY OVERVIEW(continued)
INVESTOR RELATIONS MPW
Tim Berryman | Director - Investor Relations LISTED
(205) 397-8589 NYSE
tberryman@medicalpropertiestrust.com
CAPITAL MARKETS
Charles Lambert | Managing Director - Capital Markets
(205) 397-8897
clambert@medicalpropertiestrust.com
TRANSFER AGENT STOCK EXCHANGE SENIOR UNSECURED
American Stock Transfer LISTING AND DEBT RATINGS
and Trust Company TRADING SYMBOL Moody’s – Ba1
6201 15th Avenue New York Stock Exchange Standard & Poor’s – BBB-
Brooklyn, NY 11219 (NYSE): MPW
CONTINUUM OF CARE
HIGHER MEDICAL PROPERTIES TRUST FOCUSES ON THE MOST
CRITICAL COMPONENTS OF HEALTHCARE DELIVERY.
ACUTE CARE
HOSPITALS
ACUTE CARE HOSPITALS & FREE STANDING EMERGENCY ROOMS
LONG-TERM ACUTE CARE HOSPITALS
INPATIENT REHABILITATION FACILITIES
LONG-TERM NURSING HOMES
ACUTE CARE ASSISTED LIVING
HOSPITALS HOME HEALTH CARE
MPT facility types shown in green.
INPATIENT HOME
REHABILITATION HEALTH
FACILITIES CARE
INTENSITY OF CARE
ASSISTED
NURSING HOMES LIVING
LOWER
Q4 2016 | SUPPLEMENTAL INFORMATION 4

---

MEDICALPROPERTIESTRUST.COM
FINANCIAL INFORMATION
RECONCILIATION OF NET INCOME TO FUNDS FROM OPERATIONS
(Unaudited)
(Amounts in thousands except per share data)
For the Three Months Ended For the Twelve Months Ended
December 31, 2016 December 31, 2015 December 31, 2016 December 31, 2015
FFO INFORMATION:
Net income attributable to MPT common stockholders $43,039 $58,238 $225,048 $139,598
Participating securities’ share in earnings (129) (248) (559) (1,029)
Net income, less participating securities’ share in earnings $42,910 $57,990 $224,489 $138,569
Depreciation and amortization(A) 26,976 20,140 96,157 69,867
Gain on sale of real estate - - (67,168) (3,268)
Funds from operations $69,886 $78,130 $253,478 $205,168
Write-off straight line rent and other - - 3,063 3,928
Transaction costs from non-real estate dispositions 70 - 5,944 -
Acquisition expenses, net of tax benefit(A) 34,806 4,345 46,529 61,342
Release of valuation allowance (3,956) - (3,956) -
Impairment charges (66) - 7,229 -
Unutilized financing fees / debt refinancing costs - 48 22,539 4,367
Normalized funds from operations $100,740 $82,523 $334,826 $274,805
Share-based compensation 2,111 2,521 7,942 10,237
Debt costs amortization 1,814 1,792 7,613 6,085
Additional rent received in advance(B) (300) (300) (1,200) (1,200)
Straight-line rent revenue and other (16,921) (11,118) (50,687) (34,218)
Adjusted funds from operations $87,444 $75,418 $298,494 $255,709
PER DILUTED SHARE DATA:
Net income, less participating securities’ share in earnings $0.13 $0.24 $0.86 $0.63
Depreciation and amortization(A) 0.09 0.09 0.37 0.32
Gain on sale of real estate - - (0.26) (0.01)
Funds from operations $0.22 $0.33 $0.97 $0.94
Write-off straight line rent and other - - 0.01 0.02
Transaction costs from non-real estate dispositions - - 0.02 -
Acquisition expenses, net of tax benefit(A) 0.11 0.02 0.18 0.28
Release of valuation allowance (0.02) - (0.02) -
Impairment charges - - 0.03 -
Unutilized financing fees / debt refinancing costs - - 0.09 0.02
Normalized funds from operations $0.31 $0.35 $1.28 $1.26
Share-based compensation 0.01 0.01 0.03 0.05
Debt costs amortization 0.01 0.01 0.02 0.03
Additional rent received in advance(B) - - - (0.01)
Straight-line rent revenue and other (0.06) (0.05) (0.19) (0.16)
Adjusted funds from operations $0.27 $0.32 $1.14 $1.17
(A) In 2016, this includes our share of real estate depreciation and acquisition expenses from unconsolidated joint ventures (if any). Any such amounts are included with the activity of all of our equity interests in the “Other income (expense)” line on the consolidated statements of income.
(B) Represents additional rent received from one tenant in advance of when we can recognize as revenue for accounting purposes. This additional rent is being recorded to revenue on a straight-line basis over the lease life.
Investors and analysts following the real estate industry utilize funds from operations, or FFO, as a supplemental performance measure. FFO, reflecting the assumption that real estate asset values rise or fall with market conditions, principally adjusts for the effects of GAAP depreciation and amortization of real estate assets, which assumes that the value of real estate diminishes predictably over time. We compute FFO in accordance with the definition provided by the National Association of Real Estate Investment Trusts, or NAREIT, which represents net income (loss) (computed in accordance with GAAP), excluding gains (losses) on sales of real estate and impairment charges on real estate assets, plus real estate depreciation and amortization and after adjustments for unconsolidated partnerships and joint ventures.
In addition to presenting FFO in accordance with the NAREIT definition, we also disclose normalized FFO, which adjusts FFO for items that relate to unanticipated or non-core events or activities or accounting changes that, if not noted, would make comparison to prior period results and market expectations less meaningful to investors and analysts. We believe that the use of FFO, combined with the required GAAP presentations, improves the understanding of our operating results among investors and the use of normalized FFO makes comparisons of our operating results with prior periods and other companies more meaningful. While FFO and normalized FFO are relevant and widely used supplemental measures of operating and financial performance of REITs, they should not be viewed as a substitute measure of our operating performance since the measures do not reflect either depreciation and amortization costs or the level of capital expenditures and leasing costs necessary to maintain the operating performance of our properties, which can be significant economic costs that could materially impact our results of operations. FFO and normalized FFO should not be considered an alternative to net income (loss) (computed in accordance with GAAP) as indicators of our financial performance or to cash flow from operating activities (computed in accordance with GAAP) as an indicator of our liquidity.
We calculate adjusted funds from operations, or AFFO, by subtracting from or adding to normalized FFO (i) unbilled rent revenue, (ii) non-cash share-based compensation expense, and (iii) amortization of deferred financing costs. AFFO is an operating measurement that we use to analyze our results of operations based on the receipt, rather than the accrual, of our rental revenue and on certain other adjustments. We believe that this is an important measurement because our leases generally have significant contractual escalations of base rents and therefore result in recognition of rental income that is not collected until future periods, and costs that are deferred or are non-cash charges. Our calculation of AFFO may not be comparable to AFFO or similarly titled measures reported by other REITs. AFFO should not be considered as an alternative to net income (calculated pursuant to GAAP) as an indicator of our results of operations or to cash flow from operating activities (calculated pursuant to GAAP) as an indicator of our liquidity.
Q4 2016 | SUPPLEMENTAL INFORMATION 5

---

MEDICALPROPERTIESTRUST.COM
FINANCIAL INFORMATION
DEBT SUMMARY
(as of December 31, 2016)
($ amounts in thousands)
Debt Instrument Rate Type Rate Balance
Northland – Mortgage Capital Term Loan Fixed 6.20% $13,101
2018 Credit Facility Revolver Variable 2.17% (A) 290,000
2019 Term Loan Variable 2.41% (A) 250,000
5.750% Notes Due 2020 (Euro) (B) Fixed 5.75% 210,340
4.000% Notes Due 2022 (Euro) (B) Fixed 4.00% 525,850
6.375% Notes Due 2022 Fixed 6.38% 350,000
6.375% Notes Due 2024 Fixed 6.38% 500,000
5.500% Notes Due 2024 Fixed 5.50% 300,000
5.250% Notes Due 2026 Fixed 5.25% 500,000
$2,939,291
Debt premium 1,814
Debt issuance costs (31,764)
Weighted average rate 4.87% $2,909,341
Rate Type as Percentage of Total Debt
Variable 18.4%
Fixed 81.6%
(A) At December 31, 2016, our credit facility consisted of a $1.3 billion unsecured revolving credit facility and a $250 million term loan. Our credit facility was amended and restated on February 1, 2017.
(B) Represents 700 million of bonds issued in euros and converted to U.S. dollars at December 31, 2016. With the amended and restated credit facility, we have a new €200 million term loan, proceeds of which will be used to redeem the €200 million 5.750% 2020 Senior Notes (Euro).
Q4 2016 | SUPPLEMENTAL INFORMATION 6

---

MEDICALPROPERTIESTRUST.COM
FINANCIAL INFORMATION
PRO FORMA DEBT MATURITY SCHEDULE (A)
($ amounts in thousands)
Debt Instrument 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Northland – Mortgage Capital Term Loan $320 $12,781 $— $— $— $— $— $— $— $—
2021 Credit Facility Revolver — — — — 290,000 — — — — —
2022 Credit Facility Term Loan — — — — — 200,000 — — — —
2020 Credit Facility Term Loan (Euro) — — — 210,340 — — — — — —
4.000% Notes Due 2022 (Euro) — — — — — 525,850 — — — —
6.375% Notes Due 2022 — — — — — 350,000 — — — —
6.375% Notes Due 2024 — — — — — — — 500,000 — —
5.500% Notes Due 2024 — — — — — — — 300,000 — —
5.250% Notes Due 2026 — — — — — — — — — 500,000
$320 $12,781 $— $210,340 $290,000 $1,075,850 $— $800,000 $— $500,000
$1,200,000
$1,075,850
$1,000,000
$800,000 $800,000
$600,000
$500,000
$400,000
$290,000
$210,340
$200,000
$12,781
$— $320 $— $— $—
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Northland – Mortgage Capital Term Loan 2021 Credit Facility Revolver 2022 Credit Facility Term Loan
2020 Credit Facility Term Loan (Euro) 4.000% Notes Due 2022 (Euro) 6.375% Notes Due 2022
6.375% Notes Due 2024 5.500% Notes Due 2024 5.250% Notes Due 2026
(A) Debt maturity schedule is adjusted for the closing of the February 1, 2017 credit facility and the redemption of the €200 million 5.750% 2020 Senior Notes (Euro), which has a redemption date of March 4, 2017.
Q4 2016 | SUPPLEMENTAL INFORMATION 7

---

MEDICALPROPERTIESTRUST.COM
FINANCIAL INFORMATION
PRO FORMA NET DEBT / ANNUALIZED EBITDA
(Unaudited)
(Amounts in thousands)
For the Three Months Ended
December 31, 2016
Net income attributable to MPT common stockholders $43,039
Pro forma adjustments for acquisitions that occurred after the period (A) 6,978
Pro forma net income $50,017
Add back:
Interest expense 38,465
Depreciation and amortization 28,332
Stock-based compensation 2,111
Mid-quarter acquisitions / divestitures 2,766
Gain on sale of real estate and other asset dispositions, net 70
Impairment and other charges (66)
Acquisition expenses 39,905
Income tax benefit (8,003)
4Q 2016 Pro forma EBITDA $153,597
Annualization $614,388
Total debt $2,909,341
Pro forma changes to debt balance after December 31, 2016 (A) 355,340
Cash (118,536)
Net debt $3,146,145
Net debt / pro forma annualized EBITDA 5.1x
(A) Reflects impact from previously disclosed divestitures and investments, including the two RCCH facilities and 14 facilities in Germany.
Q4 2016 | SUPPLEMENTAL INFORMATION 8

---

MEDICALPROPERTIESTRUST.COM
PORTFOLIO INFORMATION
LEASE AND MORTGAGE LOAN MATURITY SCHEDULE
(as of December 31, 2016)
($ amounts in thousands)
Years of Maturities (A) Total Leases/Loans (B) Base Rent/Interest (C) Percent of Total Base Rent/Interest
2017 — $— —
2018 1 2,016 0.4%
2019 2 5,017 0.9%
2020 5 10,662 1.9%
2021 3 13,125 2.3%
2022 15 72,532 12.9%
2023 4 12,630 2.2%
2024 1 2,237 0.4%
2025 7 21,927 3.9%
2026 5 24,598 4.4%
Thereafter 188 396,662 70.7%
231 $561,406 100.0%
Percentage of Total Base Rent/Interest
80%
70.7%
70%
60%
50%
40%
30%
20% 12.9%
10% 3.9% 4.4%
0.0% 0.4% 0.9% 1.9% 2.3% 2.2% 0.4%
0%
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 Thereafter
(A) Lease/Loan expiration is based on the fixed term of the lease/loan and does not factor in potential renewal options provided for in our agreements.
(B) Excludes six of our facilities that are under development, our Twelve Oaks facility that is not fully occupied, and the nine properties that we own through joint venture arrangements. In addition, the schedule reflects post December 31, 2016 transactions and commitments, including the the acquisition of two RCCH facilities and the remaining 14 facilities in Germany.
(C) Represents base rent/interest income on an annualized basis but does not include tenant recoveries, additional rents and other lease-related adjustments to revenue (i.e., straight-line rents and deferred revenues).
Q4 2016 | SUPPLEMENTAL INFORMATION 9

---

MEDICALPROPERTIESTRUST.COM
PORTFOLIO INFORMATION
INVESTMENTS AND REVENUE BY ASSET TYPE
(December 31, 2016)
($ amounts in thousands)
Asset Types Total Gross Assets (B) Percentage of Gross Assets YTD Revenue Percentage of Total Revenue
General Acute Care Hospitals (A) $4,738,642 66.4% $344,523 63.7%
Inpatient Rehabilitation Hospitals 1,730,106 24.2% 149,964 27.7%
Long-Term Acute Care Hospitals 373,470 5.2% 46,650 8.6%
Other assets 300,903 4.2% — —
Total $7,143,121 100.0% $541,137 100.0%
Domestic Investments by Asset Type
9.0% 6.6% 4.6% 79.8%
General Acute Care
Hospitals (A)
Inpatient Rehabilitation Hospitals
Long-Term Acute Care Hospitals
Other assets
Total Investments by Asset Type
5.2% 24.2% 4.2% 66.4%
General Acute Care
Hospitals (A)
Inpatient Rehabilitation Hospitals
Long-Term Acute Care Hospitals
Other assets
Domestic Revenue by Asset Type
12.9% 10.6% 76.5%
Total Revenue by Asset Type
27.7% 8.6% 63.7%
(A) Includes three medical office buildings.
(B) Represents investment concentration as a percentage of gross real estate assets, other loans, and equity investments assuming all real estate commitments, such as the remaining new MEDIAN acquisitions, are fully funded.
Q4 2016 | SUPPLEMENTAL INFORMATION 10

---

MEDICALPROPERTIESTRUST.COM
PORTFOLIO INFORMATION
INVESTMENTS AND REVENUE BY OPERATOR
(December 31, 2016)
($ amounts in thousands)
Operators
Total Gross Assets (A)
Percentage of Gross Assets
YTD Revenue
Percentage of Total Revenue
Steward $1,250,000 17.5% $26,098 4.8%
Prime Healthcare 1,144,055 16.0% 120,558 22.3%
MEDIAN 993,677 13.9% 93,425 17.3%
Ernest Health 627,906 8.8% 67,742 12.5%
RCCH 566,600 7.9% 52,720 9.7%
25 operators 2,259,980 31.7% 180,594 33.4%
Other assets 300,903 4.2% —   —  
Total $7,143,121 100.0% $541,137 100.0%
(A) Represents investment concentration as a percentage of gross real estate assets, other loans, and equity investments assuming all real estate commitments, such as the remaining new MEDIAN acquisitions, are fully funded.
Investments by Operator
31.7%
4.2%
17.5%
16.0%
7.9%
8.8%
13.9%
Steward
Prime Healthcare
MEDIAN
Ernest Health
RCCH
25 operators
Other assets
Revenue by Operator
33.4%
4.8%
22.3%
9.7%
12.5%
17.3%
Q4 2016 | SUPPLEMENTAL INFORMATION 11

---

MEDICALPROPERTIESTRUST.COM
PORTFOLIO INFORMATION
INVESTMENTS AND REVENUE BY U.S. STATE AND COUNTRY
(December 31, 2016) ($ amounts in thousands)
U.S. States and Other Countries
Total Gross Assets
Percentage of Gross Assets
YTD Revenue
Percentage of Total Revenue
Massachusetts $1,250,000 17.5% $26,098 4.8%
Texas 947,443 13.3% 96,992 17.9%
California 542,889 7.6% 66,197 12.2%
New Jersey 447,436 6.3% 39,084 7.2%
Arizona 331,834 4.6% 23,798 4.4%
25 Other States 1,894,047 26.5% 187,363 34.7%
Other assets(A) 264,215 3.7% —   —  
United States $5,677,864 79.5% $439,532 81.2%
Germany $1,281,649 17.9% $97,382 18.0%
Italy(A) 89,511 1.3% —   —  
United Kingdom 34,861 0.5% 3,871 0.7%
Spain(A) 22,548 0.3% 352 0.1%
Other assets(A) 36,688 0.5% —   —  
International $1,465,257 20.5% $101,605 18.8%
Total $7,143,121(B) 100.0% $541,137 100.0%
(A) Includes our equity investments, of which related income is reflected in other income in our income statement.
(B) Represents investment concentration as a percentage of gross real estate assets, other loans, and equity investments assuming all real estate commitments, such as the remaining new MEDIAN acquisitions, are fully funded.
Investments by Country
1.3% 0.5% 0.3% 0.5% 17.9% 79.5%
Investments by U.S. State
3.7% 17.5% 26.5% 13.3% 7.6% 4.6% 6.3%
United States
Germany
Italy(A)
United Kingdom
Spain(A)
Other assets(A)
Massachusetts
Texas
California
New Jersey
Arizona
25 Other States
Other assets(A)
Revenue by Country
0.7% 0.1% 18.0% 81.2%
Revenue by U.S. State
4.8% 17.9% 34.7% 12.2% 4.4% 7.2%
Q4 2016 | SUPPLEMENTAL INFORMATION 12

---

MEDICALPROPERTIESTRUST.COM
PORTFOLIO INFORMATION
Same Store EBITDAR(1) Rent Coverage
YOY and Sequential Quarter Comparisons by Property Type
6.00x
5.00x
4.00x
3.00x
2.00x
1.00x
0.00x
4.2x
4.4x
4.2x
4.0x
3.3x
3.5x
3.4x
3.4x
2.0x
1.9x
1.9x
1.7x
2.0x
2.0x
1.6x
General Acute Care Hospitals
Inpatient Rehabilitation Facilities
Long-Term Acute Care Hospitals
Total Portfolio
Q3 2015 (YoY)
Q3 2016 (YoY)
Q2 2016 (QoQ)
Q3 2016 (QoQ)
Stratification of Portfolio EBITDAR Rent Coverage
EBITDAR Rent Coverage TTM
Greater than or equal to 4.50x
3.00x - 4.49x
1.50x - 2.99x
Less than 1.50x
Total Master Leased and/or with Parent
Guaranty: 2.7x
General Acute Master Leased and/or with
Parent Guaranty: 3.4x
Inpatient Rehabilitation Facilities Master
Leased and/or with Parent Guaranty: 2.0x
Long-Term Acute Care Hospitals Master
Leased and/or with Parent Guaranty: 1.6x
Investment (in thousands)
$277,907
$270,552
$29,467
$112,047
$1,846,140
$906,700
$575,755
$363,685
No. of Facilities
5 3 1 1 66 22 27 17
Percentage of Investment
11.0% 10.7% 1.2% 4.4% 72.7% 35.7% 22.7% 14.3%
14.3% 11.0% 10.7% 1.2% 22.7% 4.4% 35.7%
Greater than or equal to 4.50x
3.00x - 4.49x
1.50x - 2.99x
Less than 1.50x
General Acute Master Lease or Parent
Guaranty
Rehab Master Lease or Parent Guaranty
LTACH Master Lease or Parent Guaranty
Notes:
Same Store represents properties with at least 24 months of financial reporting data. Properties that do not provide financial reporting and disposed assets are not included.
Freestanding ERs will be reported as a distinct property type when 24 months of financial reporting data is available for a property or all properties associated with a funding commitment as applicable.
All data presented is on a trailing twelve month basis.
(1) EBITDAR adjusted for non-recurring items.
Q4 2016 | SUPPLEMENTAL INFORMATION 13

---

MEDICALPROPERTIESTRUST.COM
PORTFOLIO INFORMATION
SUMMARY OF COMPLETED ACQUISITIONS / DEVELOPMENT PROJECTS FOR THE THREE MONTHS ENDED DECEMBER 31, 2016
($ amounts in thousands)
Operator
Adeptus Health
Adeptus Health
Adeptus Health
Adeptus Health
Adeptus Health
Adeptus Health
Steward
MEDIAN & Affiliates
Location
San Antonio, TX
Dallas, TX
New Orleans, LA
San Antonio, TX
Phoenix, AZ
Houston, TX
Massachusetts
Germany
Costs Incurred as of 12/31/2016
$5,157
4,954
7,804
4,837
7,148
4,671
1,250,000
89,529(A)
$1,374,100
Rent Commencement Date
12/9/2016
11/15/2016
10/28/2016
10/27/2016
10/21/2016
10/10/2016
10/3/2016
Various (B)
Acquisition/ Development
Development
Development
Development
Development
Development
Development
Acquisition
Acquisition
(A) Excludes any equity investment contribution to retain our 5.1% interest in MEDIAN.
(B) Twelve properties commenced rent in the 4Q 2016 at various dates.
SUMMARY OF CURRENT INVESTMENT COMMITMENTS AS OF DECEMBER 31, 2016
($ amounts in thousands)
Operator
MEDIAN & Affiliates
RCCH
Location
Germany
Idaho & Washington
Commitment
$183,647
105,000
$288,647
Acquisition/ Development
Acquisition
Acquisition
SUMMARY OF CURRENT DEVELOPMENT PROJECTS AS OF DECEMBER 31, 2016
($ amounts in thousands)
Operator Commitment
Costs Incurred as of 12/31/2016
Estimated Completion Date
Adeptus Health
$5,848 $2,710 1Q 2017
Adeptus Health 67,185 44,948 2Q 2017
Ernest Health 28,067 4,342 4Q 2017
Adeptus Health 7,804 1,648 1Q 2018
Adeptus Health 53,866 —  
Various $162,770 $53,648
Q4 2016 | SUPPLEMENTAL INFORMATION 14

---

MEDICALPROPERTIESTRUST.COM
FINANCIAL STATEMENTS
MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES
Consolidated Statements of Income
(Amounts in thousands except per share data)
For the Three Months Ended For the Twelve Months Ended
December 31, 2016 December 31, 2015 December 31, 2016 December 31, 2015
(Unaudited) (Unaudited) (Unaudited) (A)
Revenues
Rent billed $92,861 $70,253 $327,269 $247,604
Straight-line rent 14,558 8,372 41,067 23,375
Income from direct financing leases 17,126 18,660 64,307 58,715
Interest and fee income 28,738 34,261 108,494 112,184
Total revenues 153,283 131,546 541,137 441,878
Expenses
Real estate depreciation and amortization 26,524 20,140 94,374 69,867
Impairment charges (66) — 7,229 —
Property-related 1,120 1,184 2,712 3,792
Acquisition expenses 39,894 4,345 46,273 61,342
General and administrative 13,090 11,314 48,911 43,639
Total operating expenses 80,562 36,983 199,499 178,640
Operating income 72,721 94,563 341,638 263,238
Interest expense (38,465) (35,923) (159,597) (120,884)
Gain (loss) on sale of real estate and other asset dispositions, net (70) — 61,224 3,268
Unutilized financing fees/debt refinancing costs — (48) (22,539) (4,367)
Other income (expense) 1,056 230 (1,618) 175
Income tax benefit (expense) 8,003 (484) 6,830 (1,503)
Income from continuing operations 43,245 58,338 225,938 139,927
Loss from discontinued operations — — (1) —
Net income 43,245 58,338 225,937 139,927
Net income attributable to non-controlling interests (206) (100) (889) (329)
Net income attributable to MPT common stockholders $43,039 $58,238 $225,048 $139,598
Earnings per common share – basic:
Income from continuing operations $0.13 $0.24 $0.86 $0.64
Loss from discontinued operations — — — —
Net income attributable to MPT common stockholders $0.13 $0.24 $0.86 $0.64
Earnings per common share – diluted:
Income from continuing operations $0.13 $0.24 $0.86 $0.63
Loss from discontinued operations — — — —
Net income attributable to MPT common stockholders $0.13 $0.24 $0.86 $0.63
Dividends declared per common share $0.23 $0.22 $0.91 $0.88
Weighted average shares outstanding – basic 319,833 237,011 260,414 217,997
Weighted average shares outstanding – diluted 319,994 237,011 261,072 218,304
(A) Financials have been derived from the prior year audited financial statements.
Q4 2016 | SUPPLEMENTAL INFORMATION 15

---

MEDICALPROPERTIESTRUST.COM
FINANCIAL STATEMENTS
MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES
Consolidated Balance Sheets
(Amounts in thousands except per share data)
December 31, 2016 December 31, 2015
(Unaudited) (A)
ASSETS
Real estate assets
Land, buildings and improvements, intangible lease assets, and other $4,317,866 $3,297,705
Net investment in direct financing leases 648,102 626,996
Mortgage loans 1,060,400 757,581
Gross investment in real estate assets 6,026,368 4,682,282
Accumulated depreciation and amortization (325,125) (257,928)
Net investment in real estate assets 5,701,243 4,424,354
Cash and cash equivalents 83,240 195,541
Interest and rent receivables 57,698 46,939
Straight-line rent receivables 116,861 82,155
Other assets 459,494 860,362
Total Assets $6,418,536 $5,609,351
LIABILITIES AND EQUITY
Liabilities
Debt, net $2,909,341 $3,322,541
Accounts payable and accrued expenses 207,711 137,356
Deferred revenue 19,933 29,358
Lease deposits and other obligations to tenants 28,323 12,831
Total liabilities 3,165,308 3,502,086
Equity
Preferred stock, $0.001 par value. Authorized 10,000 shares; no shares outstanding — —
Common stock, $0.001 par value. Authorized 500,000 shares; issued and outstanding - 320,514 shares at December 31, 2016 and 236,744 shares at December 31, 2015 321 237
Additional paid in capital 3,775,336 2,593,827
Distributions in excess of net income (434,114) (418,650)
Accumulated other comprehensive loss (92,903) (72,884)
Treasury shares, at cost (262) (262)
Total Medical Properties Trust, Inc. Stockholders’ Equity 3,248,378 2,102,268
Non-controlling interests 4,850 4,997
Total equity 3,253,228 2,107,265
Total Liabilities and Equity $6,418,536 $5,609,351
(A) Financials have been derived from the prior year audited financial statements.
Q4 2016 | SUPPLEMENTAL INFORMATION 16

---

MEDICALPROPERTIESTRUST.COM
FINANCIAL STATEMENTS
OTHER INCOME GENERATING ASSETS AS OF DECEMBER 31, 2016
($ amounts in thousands)
Operator Investment Annual Interest Rate YTD RIDEA Income (A) Security / Credit Enhancements
Non-Operating Loans
(B) Secured and cross-defaulted with real estate,
Vibra Healthcare acquisition loan $6,478 10.25%
other agreements and guaranteed by Parent
Secured and cross-defaulted with real estate and
Alecto working capital 12,500 11.22%
guaranteed by Parent
Secured and cross-defaulted with real estate and
IKJG/HUMC working capital 8,225 10.40%
guaranteed by Parent
Secured and cross-defaulted with real estate and
Ernest Health 23,098 9.10%
guaranteed by Parent
Other 12,218
62,519
Operating Loans
(C) Secured and cross-defaulted with real estate and
Ernest Health 93,200 15.00% $15,317
guaranteed by Parent
Equity investments(D)
Domestic(E) 62,565 1,045
International(F) 114,865 4,893 (G)
(A) Income earned on operating loans is reflected in the interest income line of the income statement.
(B) Original amortizing acquisition loan was $41 million; loan matures in 2019.
(C) Due to compounding, effective interest rate is 16.4%.
(D) All earnings in income from equity investments are reported on a one quarter lag basis.
(E) Includes $50 million preferred interest in Steward.
(F) Includes equity investments in Spain, Italy, and Germany.
(G) Excludes our share of real estate depreciation and acquisition expenses of certain unconsolidated joint ventures.
Q4 2016 | SUPPLEMENTAL INFORMATION 17

---

MPT
Medical Properties Trust
1000 Urban Center Drive, Suite 501
Birmingham, AL 35242
(205) 969-3755 NYSE: MPW
www.medicalpropertiestrust.com
Contact:
Charles Lambert, Managing Director - Capital Markets
(205) 397-8897 or clambert@medicalpropertiestrust.com
or
Tim Berryman, Director - Investor Relations
(205) 397-8589 or tberryman@medicalpropertiestrust.com
AT THE VERY HEART OF HEALTHCARE®.